ORIONINFU Orion Infusion Ltd.
Pharmaceuticals & Chemicals
Tk 209.9 as of 2026-11-12 14:09:55
Rank 118 of all scored
Data completeness 100%
Data completeness 100%
Score breakdown
Consistency 79
Profitability 51
Solvency 68
Valuation 0
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Strengths
- Consistency Paid a dividend every year (5/5)
Concerns
- Valuation P/E 146.78 is high (above 20)
- Valuation Trades at 12.9x book value (NAV Tk 16.27, price Tk 209.9)
- Valuation Price is 817% above the Graham fair value (Tk 22.9)
Notes
- Consistency EPS rose in 2 of 4 years (mixed)
- Profitability Average ROE 13.68% (moderate)
- Solvency Debt/equity 0.92x (well managed)
Risk flags
- Mid cap (Tk 200-1,000 cr)
Valuation
P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety
52-week range
32% above the low, 47.4% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)
Dividends and safety
Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap
Size, liquidity and ownership
MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %
Shareholding
- Sponsor/director 40.6%
- Institution 10.5%
- Foreign 0.1%
- Public 48.8%
Audited history
| Year | EPS (Tk) | NAV/share | Net profit (cr) | Cash div % | Bonus % |
|---|---|---|---|---|---|
| 2021 | 1.37 | 13.1 | 3 | 10 | 0 |
| 2022 | 2.1 | 14.22 | 4 | 20 | 0 |
| 2023 | 2.06 | 14.32 | 4 | 10 | 0 |
| 2024 | 2.08 | 15.45 | 4 | 12 | 0 |
| 2025 | 1.72 | 16.02 | 4 | 20 | 0 |
Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 7.2%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.